DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

Definition: A microarray is a small, flat substrate carrying an ordered grid of microscopic probe features, each containing a known biological molecule, that is used to measure many molecular targets ...

Electrical and Computer Engineering Department and Physics Department, Boston University, Boston, Massachusetts 02215, and Istituto di Chimica del Riconoscimento Molecolare, CNR, Milano, Italy * To ...

The DNA diagnostics market is experiencing robust growth, driven by the increasing prevalence of genetic disorders, infectious diseases, and cancer worldwide. Rising adoption of precision medicine ...

Microarray technology encompasses a few relatively well-established methods and numerous applications that are in various stages of development. Apart from their use as a tool for diagnostic testing ...

Objective Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy. Differentiation from chronic pancreatitis (CP) is currently inaccurate in about one-third of cases. Misdiagnoses in both ...

Reviewed by Dr. Tomislav Meštrović, MD, Ph.D. The microarray is a recently developed technology used in cancer research and in the pharmacological treatment of other diseases such as oral lesions. In ...

Cancer is one of the top causes of death globally. Recently, microarray gene expression data has been used to aid in cancer’s effective and early detection. The use of DNA microarray technology to ...

Abstract: Microarray platforms such as Gene expression, oligonucleotide (GeneChip), and cDNA (complementary DNA) can play a critical role in the understanding of genome sequencing, by providing ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

Denervation induces skeletal muscle atrophy, accompanied by complex biochemical and physiological changes, with potentially devastating outcomes even an increased mortality. Currently, however, there ...

Last month, the DNA-testing company 23andMe secured Food and Drug Administration approval for a new screening for gene-based health risks. Along with celiac disease, Alzheimer’s, Parkinson’s, breast ...